| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 21, 2026 | ±2.1% | +5.4% | under-priced |
| October 28, 2025 | ±1.6% | +8.6% | under-priced |
| July 22, 2025 | ±1.9% | -8.9% | under-priced |
| April 22, 2025 | ±2.9% | +0.9% | over-priced |
| October 31, 2024 | ±3.9% | +0.4% | over-priced |
| July 23, 2024 | ±1.6% | +7.9% | under-priced |
| April 23, 2024 | ±1.9% | -13.4% | under-priced |
| October 31, 2023 | ±2.3% | -2.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $5.53 | $851M | $406M |
| Q4 FY2025 | $3.82 | $823M | $285M |
| Q3 FY2025 | $4.25 | $793M | $325M |
| Q2 FY2025 | $3.92 | $773M | $304M |
MSCI, Inc. (MSCI) reports in 81 days, with the next report estimated for September 2, 2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 6.0% on average — the market has been roughly fair on MSCI's earnings risk. Fundamentals into the print: EPS up 49.1% year-over-year, revenue up 14.1%. QuantLogix's live 5-factor engine currently reads MSCI as a buy at 53/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →